CSIR backs development of a drug for patients suffering from Gram-negative sepsis
CSIR announced that it will initiate a randomised, blinded, two arms, active comparator-controlled clinical trial to evaluate the…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.